Long-term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study
- PMID: 29888538
- PMCID: PMC6168938
- DOI: 10.1002/cncr.31379
Long-term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study
Abstract
Background: Neuroblastoma survivors may be at elevated risk for psychological impairments because of their young age at diagnosis and neurotoxic treatment, but this is not well described.
Methods: A total of 859 ≥5-year survivors of neuroblastoma younger than 18 years (diagnosed in 1970-1999), who had a median age at diagnosis of 0.8 years (range: 0.0-7.3 years) and a median follow-up of 13.3 years (range: 8.0-17.9 years), were compared with 872 siblings of childhood cancer survivors who were younger than 18 years with the parent-reported Behavior Problem Index (BPI) for psychological functioning. Age- and sex-adjusted multivariate log-binomial models were used to identify factors associated with impairment in BPI domains (scores worse than the sibling 10th percentile). The impact of psychological impairment on educational outcomes was examined among survivors.
Results: Compared with siblings, neuroblastoma survivors had an increased prevalence of impairment in the domains of anxiety/depression (19% vs 14%; P = .003), headstrong behavior (19% vs 13%; P < .001), attention deficits (21% vs 13%; P < .001), peer conflict/social withdrawal (26% vs 17%; P < .001), and antisocial behavior (16% vs 12%; P = .01). Common treatment exposures (vincristine, cisplatin, and retinoic acid) were not associated with impairment. Having 2 or more chronic health conditions predicted impairment in 4 domains (P < .001). Specifically, pulmonary disease predicted impairment in all 5 domains (P ≤ .004). Endocrine disease (P ≤ .004) and peripheral neuropathy (P ≤ .02) each predicted impairment in 3 domains. Psychological impairment was associated with special education service usage and educational attainment less than college.
Conclusions: Neuroblastoma survivors are at elevated risk for psychological impairment, which is associated with special education service usage and lower adult educational attainment. Those with chronic health conditions may represent a high-risk group for targeted screening and intervention. Cancer 2018. © 2018 American Cancer Society.
Keywords: cancer survivorship; chronic health; educational outcomes; neuroblastoma; psychological outcomes.
© 2018 American Cancer Society.
Conflict of interest statement
Figures


Similar articles
-
Neurocognitive outcomes in adult survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study.Cancer. 2023 Sep 15;129(18):2904-2914. doi: 10.1002/cncr.34847. Epub 2023 May 18. Cancer. 2023. PMID: 37199722 Free PMC article.
-
Social adjustment in adolescent survivors of pediatric central nervous system tumors: A report from the Childhood Cancer Survivor Study.Cancer. 2018 Sep 1;124(17):3596-3608. doi: 10.1002/cncr.31593. Epub 2018 Aug 1. Cancer. 2018. PMID: 30067866 Free PMC article.
-
Psychological, educational, and social late effects in adolescent survivors of Wilms tumor: A report from the Childhood Cancer Survivor Study.Psychooncology. 2021 Mar;30(3):349-360. doi: 10.1002/pon.5584. Epub 2020 Nov 9. Psychooncology. 2021. PMID: 33113206 Free PMC article.
-
Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.J Clin Oncol. 2009 May 10;27(14):2396-404. doi: 10.1200/JCO.2008.21.1433. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255309 Free PMC article. Review.
-
Psychological Symptoms, Social Outcomes, Socioeconomic Attainment, and Health Behaviors Among Survivors of Childhood Cancer: Current State of the Literature.J Clin Oncol. 2018 Jul 20;36(21):2190-2197. doi: 10.1200/JCO.2017.76.5552. Epub 2018 Jun 6. J Clin Oncol. 2018. PMID: 29874134 Free PMC article. Review.
Cited by
-
Adaptations to a Generalized Radiation Dose Reconstruction Methodology for Use in Epidemiologic Studies: An Update from the MD Anderson Late Effect Group.Radiat Res. 2019 Aug;192(2):169-188. doi: 10.1667/RR15201.1. Epub 2019 Jun 18. Radiat Res. 2019. PMID: 31211642 Free PMC article.
-
Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review.Lancet Haematol. 2020 May;7(5):e408-e417. doi: 10.1016/S2352-3026(20)30064-8. Lancet Haematol. 2020. PMID: 32359452 Free PMC article.
-
Functional polymorphisms of the TET1 gene increase the risk of neuroblastoma in Chinese children.J Cell Mol Med. 2023 Aug;27(15):2239-2248. doi: 10.1111/jcmm.17820. Epub 2023 Jun 22. J Cell Mol Med. 2023. PMID: 37347215 Free PMC article.
-
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment.Cancers (Basel). 2022 Sep 12;14(18):4421. doi: 10.3390/cancers14184421. Cancers (Basel). 2022. PMID: 36139583 Free PMC article. Review.
-
Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model.Oncoimmunology. 2019 May 27;8(8):1593804. doi: 10.1080/2162402X.2019.1593804. eCollection 2019. Oncoimmunology. 2019. PMID: 31413905 Free PMC article.
References
-
- Horner M, Ries L, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2006, National Cancer Institute. Bethesda, MD, 2009.
-
- Weinstein JL, Katzenstein HM, Cohn SL. Advances in the diagnosis and treatment of neuroblastoma. The Oncologist. 2003;8: 278–292. - PubMed
-
- Laverdière C, Cheung NKV, Kushner BH, et al. Long‐term complications in survivors of advanced stage neuroblastoma. Pediatric blood & cancer. 2005;45: 324–332. - PubMed
-
- Carpentieri S, Diller L. Neuropsychological resiliency after treatment for advanced stage neuroblastoma. Bone marrow transplantation. 2005;35: 1117–1122. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical